Serum fibroblast growth factor 19 serves as a potential novel biomarker for hepatocellular carcinoma

Serum fibroblast growth factor 19 serves as a potential novel biomarker for hepatocellular carcinoma

Abstract Background Abnormal autocrine fibroblast growth factor 19 (FGF19) production has been observed in several types of cancers, including hepatocellular carcinoma (HCC). In this study, we investigated the potential of serum FGF19 as a novel tumor marker of HCC based on a sandwich enzyme-linked...

Full description

Bibliographic Details
Main Authors: Takahiro Maeda, Hiroaki Kanzaki, Tetsuhiro Chiba, Junjie Ao, Kengo Kanayama, Susumu Maruta, Yuko Kusakabe, Tomoko Saito, Kazufumi Kobayashi, Soichiro Kiyono, Masato Nakamura, Sadahisa Ogasawara, Eiichiro Suzuki, Yoshihiko Ooka, Shingo Nakamoto, Ryo Nakagawa, Ryosuke Muroyama, Tatsuo Kanda, Hitoshi Maruyama, Naoya Kato
Format: Article
Language:English
Published: BMC 2019-11-01
Series:BMC Cancer
Subjects:
FGF19
HCC
Tumor marker
AFP
RFA
Online Access:http://link.springer.com/article/10.1186/s12885-019-6322-9

Internet

http://link.springer.com/article/10.1186/s12885-019-6322-9

Similar Items